Blueprint Medicines

Cambridge, United States

Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.

Jun 2022

Post-IPO Equity

Bioinformatics Biotechnology Health Care Medical

Top Investors

RA Capital ManagementWellington ManagementSixth StreetPerceptive AdvisorsRedmile Group

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Blueprint Medicines

Who are Blueprint Medicines's investors?

Blueprint Medicines's investors include RA Capital Management, Wellington Management, Sixth Street, Perceptive Advisors, Redmile Group.

Where is Blueprint Medicines headquartered?

Blueprint Medicines is headquartered in Cambridge, United States.

What does Blueprint Medicines do?

Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.

What stage is Blueprint Medicines at?

Blueprint Medicines is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 30, 2022.

MLA

"Blueprint Medicines — Funding & Investors." VCBacked, June 30, 2022, https://www.vcbacked.co/company/blueprint-medicines. Accessed July 1, 2026.

APA

VCBacked. (2022). Blueprint Medicines — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/blueprint-medicines

Wikipedia (cite web)

{{cite web |title=Blueprint Medicines — Funding & Investors |url=https://www.vcbacked.co/company/blueprint-medicines |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 30, 2022.

Similar Companies in Bioinformatics

View all

Lifebit

London

Constantiam Biosciences